On 9 March, Xeltis CEO Laurent Grandidier will be presenting at BioCapital Europe Conference, Europe’s premier life sciences investment conference, offering VCs and institutional investors unique and timely access to around 40 exciting European biotech companies.
Organized by LSP (Life Science Partners), BioCapital Europe is now in its 14th year, demonstrating the success of past editions for investors and biotech companies alike. 2015 was a significant year for Xeltis, as it continued its transformation into one of the world’s most promising medtech start-ups.
For further information on the meeting please visit the BioCapital website.
